UnannouncedVCInvestor

MBX Capital

Startup rounds since 2021 with a MBX Capital investor on the board, and the firm's own fund filings.

Raises
6
since 2021
Unannounced
3
no announcement found, of those filed since 2025
Funds
4
fund filings under the firm's name

Rounds

  1. Neurofold Therapeutics Inc.$6.5MUnannounced · 64 days14 Jul 2026 · Greenwood Village, CO · Biotech
  2. Contraline, Inc.$55.8MAnnounced10 Jun 2026 · Charlottesville, VA · Biotech
  3. Junction Health, Inc.$3.54MUnannounced · 117 days22 May 2026 · Denver, CO · Health care
  4. Ancilia Biosciences, Inc.$10.1MUnannounced · 163 days6 Apr 2026 · New York, NY
  5. Contraline, Inc.$7.23MFiled before 20255 Apr 2022 · Charlottesville, VA · Biotech
  6. Attivare Therapeutics, Inc.$5.88MFiled before 202517 Dec 2021 · Natick, MA

By year

YearRaisesUnannounced
202643
20221—
20211—

Raises are checked for an announcement from 2025 on.

Funds

The firm's own fund filings, each at its latest filing.

FundFiledSizeRaised
MBX Capital III-A LP11 Mar 2025$1.45M$1.45M
Mbx Capital III, LP9 Aug 2023$50M—
MBX Capital II-A, LP29 Mar 2023$4.49M$4.49M
MBX Capital II, LP11 Jan 2021$30M—

Listed because a MBX Capital fund's filing names a director of each company. A name match is not a verified identity.